Our highly efficient end-to-end CDMO service platform accelerates the process of biopharma development from DNA to IND application, and till BLA submission.
Our highly efficient end-to-end CDMO service platform accelerates the process of biopharma development from DNA to IND application, and till BLA submission.
13 months from gene synthesis to GMP compliant drug product, including one month of stability data, a proven drug development platform across all CMC activities.
Experience in commercialization of more than 5 products, including two Covid-19 vaccines. 11 months from preparation of clinical phase III information to the end of process validation